본문으로 건너뛰기
← 뒤로

The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review.

2/5 보강
Urologic oncology 📖 저널 OA 12.1% 2022: 0/1 OA 2025: 2/46 OA 2026: 13/76 OA 2022~2026 2026 Vol.44(5) p. 111008 OA Genital Health and Disease
TL;DR Current evidence on the TME in PC and novel therapeutic strategies are summarized to guide future personalized treatment strategies, aiming to guide future personalized treatment strategies.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-04-29
OpenAlex 토픽 · Genital Health and Disease Dupuytren's Contracture and Treatments Hidradenitis Suppurativa and Treatments

Fiegl A, Mink J, Junker K, Hartmann A, Eckstein M

📖 무료 전문 🔓 OA PDF oa
📝 환자 설명용 한 줄

Current evidence on the TME in PC and novel therapeutic strategies are summarized to guide future personalized treatment strategies, aiming to guide future personalized treatment strategies.

이 논문을 인용하기

↓ .bib ↓ .ris
APA August Fiegl, J. Mink, et al. (2026). The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review.. Urologic oncology, 44(5), 111008. https://doi.org/10.1016/j.urolonc.2026.111008
MLA August Fiegl, et al.. "The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review.." Urologic oncology, vol. 44, no. 5, 2026, pp. 111008.
PMID 41724630 ↗

Abstract

Penile carcinoma (PC) is a rare malignancy with substantial geographic and etiological heterogeneity. Histologically, it is stratified into HPV-associated and HPV-independent subtypes, each with distinct clinical behaviors and molecular features. Prognostic markers such as histologic tumor stage, grade, nodal involvement, and lymphovascular invasion guide therapeutic decision-making, while emerging predictive biomarkers-HPV status, PD-L1 expression, and tumor mutational burden-show potential to personalize systemic treatment. Advances in tumor microenvironment (TME) profiling have revealed immune and stromal signatures that have the potential to influence treatment response. While immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) show early clinical benefits, biomarker-driven patient selection remains essential to optimize efficacy. This review summarizes current evidence on the TME in PC and novel therapeutic strategies, aiming to guide future personalized treatment strategies.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (2)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기